Advocacy News

  The YouGov Big Survey on Drugs was recently  released attempting to examine attitudes towards and use of recreational and prescription drugs. The study was canvassed in September 2021, on…

  Ketamine is beginning to be used as a treatment for mental health conditions such as depression and addiction and although research is progressing, societal stigma has been a significant…

As part of our week-long spotlight on women in the medical cannabis sector we have had the pleasure of interviewing Hannah Deacon, Director of Maple Tree Consultants and mother of…

To kick off the first week of 2022 we are spotlighting the work of women in the medical cannabis sector. In this Volteface interview Carly Barton, Director of Cancard and…

We are dedicating the first week of January 2022 to spotlighting the work of women in the medical cannabis sector. Everyday this week we will be releasing articles featuring interviews…

  In this episode Paul, Katya and George break down all the big talking points over the past month in the world of cannabis and drug reform. Topics covered: Germany…

Following much media speculation last weekend, the government has published its highly anticipated 10-year drug strategy. This comes at a time when questions are being asked about the government’s own…

What is decriminalisation? Decriminalisation theoretically refers to the removal of a criminal sanction from an act.  What does it mean if a drug is decriminalised? When we refer to decriminalisation…

Last night the Welsh Labour MP for Newport West, Jane Bryant led a Senedd debate opening up a vital conversation about drug reform in Wales. This was an incredibly exciting…

The 15th – 21st November is Alcohol Awareness Week (AAW) in the UK, and this year’s theme is Relationships. 20 people die every day in the UK as a result…